A blueprint for biotech's blues.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19668152.
- Also identified by DOI 10.1038/nbt0809-675.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The strategy outlined in the UK's Life Sciences Blueprint is unlikely to address the British biotech sector's woes or help it regain prominence and success.
Medical subject headings
- Biotechnology